Your browser doesn't support javascript.
loading
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.
Kotb, Ahmed; Alzahrani, Hazzaa; Alahmari, Ali; Alhayli, Saud; Shaheen, Marwan; Chaudhri, Naeem; Alsharif, Fahad; Hanbali, Amr; Alfraih, Feras; Alshaibani, Alfadel; Albabtain, Abdulwahab A; Alfayez, Mansour; Alotaibi, Ahmad S; Elhassan, Tusneem; Rasheed, Walid; Almohareb, Fahad; Aljurf, Mahmoud; El Fakih, Riad.
Afiliação
  • Kotb A; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Hematology Unit, Department of Medicine, Zagazig University, Zagazig, Egypt.
  • Alzahrani H; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alahmari A; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Syed Osman Ahmed; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alhayli S; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Shaheen M; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Chaudhri N; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alsharif F; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Hanbali A; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alfraih F; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alshaibani A; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Albabtain AA; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alfayez M; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alotaibi AS; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Elhassan T; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Rasheed W; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Almohareb F; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Aljurf M; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • El Fakih R; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; School of Medicine, Alfaisal University, Riyadh, Saudi Arabia. Electronic address: riadfakih@hotmail.com.
Cytotherapy ; 25(12): 1331-1337, 2023 12.
Article em En | MEDLINE | ID: mdl-37737766
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Anemia Aplástica Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Anemia Aplástica Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito País de publicação: Reino Unido